Post-translational modifications of Hsp90 and their contributions to chaperone regulation

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 3, 2012, Pages 648-655

  Mollapour, Mehdi ^a   Neckers, Len ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Acetylation; Heat shock protein 90; Hsp82; Nitrosylation; Oxidation; Post translational modification phosphorylation

Indexed keywords

ACYLTRANSFERASE; B RAF KINASE; CHAPERONE; CYCLIC AMP DEPENDENT PROTEIN KINASE; HEAT SHOCK PROTEIN 90; PROTEIN KINASE B; PROTEIN KINASE P60; PROTEIN KINASE R;

ACETYLATION; ENZYME ACTIVITY; EUKARYOTE; HUMAN; NITROSYLATION; ONCOGENE SRC; OXIDATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; UBIQUITINATION;

ADENOSINE TRIPHOSPHATE; HSP90 HEAT-SHOCK PROTEINS; HUMANS; MOLECULAR CHAPERONES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EUKARYOTA;

EID: 84857044092     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.07.018     Document Type: Review

References (138)

1. Martin J. Chaperonin function - effects of crowding and confinement. J Mol Recognit 2004, 17:465-472.
2. Kampinga H.H. Chaperones in preventing protein denaturation in living cells and protecting against cellular stress. Handb Exp Pharmacol 2006, 1-42.
3. Wandinger S.K., Richter K., Buchner J. The Hsp90 chaperone machinery. J Biol Chem 2008, 283:18473-18477.
4. Picard D. Heat-shock protein 90, a chaperone for folding and regulation. Cell Mol Life Sci 2002, 59:1640-1648.
5. Taipale M., Jarosz D.F., Lindquist S. HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol 2010, 11:515-528.
6. Trepel J., Mollapour M., Giaccone G., Neckers L. Targeting the dynamic HSP90 complex in cancer. Nat Rev Cancer 2010, 10:537-549.
7. Whitesell L., Lindquist S.L. HSP90 and the chaperoning of cancer. Nat Rev Cancer 2005, 5:761-772.
8. Workman P., Burrows F., Neckers L., Rosen N. Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress. Ann N Y Acad Sci 2007, 1113:202-216.
9. Kim Y.S., Alarcon S.V., Lee S., Lee M.J., Giaccone G., Neckers L., Trepel J.B. Update on Hsp90 inhibitors in clinical trial. Curr Top Med Chem 2009, 9:1479-1492.
10. Large A.T., Goldberg M.D., Lund P.A. Chaperones and protein folding in the archaea. Biochem Soc Trans 2009, 37:46-51.
11. Grad I., Cederroth C.R., Walicki J., Grey C., Barluenga S., Winssinger N., De Massy B., Nef S., Picard D. The molecular chaperone Hsp90alpha is required for meiotic progression of spermatocytes beyond pachytene in the mouse. PLoS One 2010, 5:e15770.
12. Pearl L.H., Prodromou C. Structure and mechanism of the Hsp90 molecular chaperone machinery. Annu Rev Biochem 2006, 75:271-294.
13. Ali M.M., Roe S.M., Vaughan C.K., Meyer P., Panaretou B., Piper P.W., Prodromou C., Pearl L.H. Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex. Nature 2006, 440:1013-1017.
14. Prodromou C., Pearl L.H. Structure and functional relationships of Hsp90. Curr Cancer Drug Targets 2003, 3:301-323.
15. Ratzke C., Mickler M., Hellenkamp B., Buchner J., Hugel T. Dynamics of heat shock protein 90 C-terminal dimerization is an important part of its conformational cycle. Proc Natl Acad Sci U S A 2010, 107:16101-16106.
16. Tsutsumi S., Mollapour M., Graf C., Lee C.T., Scroggins B.T., Xu W., Haslerova L., Hessling M., Konstantinova A.A., Trepel J.B., Panaretou B., Buchner J., Mayer M.P., Prodromou C., Neckers L. Hsp90 charged-linker truncation reverses the functional consequences of weakened hydrophobic contacts in the N domain. Nat Struct Mol Biol 2009, 16:1141-1147.
17. Hainzl O., Lapina M.C., Buchner J., Richter K. The charged linker region is an important regulator of Hsp90 function. J Biol Chem 2009, 284:22559-22567.
18. Vaughan C.K., Gohlke U., Sobott F., Good V.M., Ali M.M., Prodromou C., Robinson C.V., Saibil H.R., Pearl L.H. Structure of an Hsp90-Cdc37-Cdk4 complex. Mol Cell 2006, 23:697-707.
19. Southworth D.R., Agard D.A. Species-dependent ensembles of conserved conformational states define the Hsp90 chaperone ATPase cycle. Mol Cell 2008, 32:631-640.
20. Shiau A.K., Harris S.F., Southworth D.R., Agard D.A. Structural analysis of E. coli hsp90 reveals dramatic nucleotide-dependent conformational rearrangements. Cell 2006, 127:329-340.
21. McLaughlin S.H., Ventouras L.A., Lobbezoo B., Jackson S.E. Independent ATPase activity of Hsp90 subunits creates a flexible assembly platform. J Mol Biol 2004, 344:813-826.
22. Meyer P., Prodromou C., Liao C., Hu B., Roe S.M., Vaughan C.K., Vlasic I., Panaretou B., Piper P.W., Pearl L.H. Structural basis for recruitment of the ATPase activator Aha1 to the Hsp90 chaperone machinery. EMBO J 2004, 23:1402-1410.
23. Krukenberg K.A., Bottcher U.M., Southworth D.R., Agard D.A. Grp94, the endoplasmic reticulum Hsp90, has a similar solution conformation to cytosolic Hsp90 in the absence of nucleotide. Protein Sci 2009, 18:1815-1827.
24. Mickler M., Hessling M., Ratzke C., Buchner J., Hugel T. The large conformational changes of Hsp90 are only weakly coupled to ATP hydrolysis. Nat Struct Mol Biol 2009, 16:281-286.
25. Hessling M., Richter K., Buchner J. Dissection of the ATP-induced conformational cycle of the molecular chaperone Hsp90. Nat Struct Mol Biol 2009, 16:287-293.
26. Neckers L. Using natural product inhibitors to validate Hsp90 as a molecular target in cancer. Curr Top Med Chem 2006, 6:1163-1171.
27. Pearl L.H., Prodromou C., Workman P. The Hsp90 molecular chaperone: an open and shut case for treatment. Biochem J 2008, 410:439-453.
28. Caplan A.J. What is a co-chaperone?. Cell Stress Chaperones 2003, 8:105-107.
29. Abbas-Terki T., Briand P.A., Donze O., Picard D. The Hsp90 co-chaperones Cdc37 and Sti1 interact physically and genetically. Biol Chem 2002, 383:1335-1342.
30. Chang H.C., Nathan D.F., Lindquist S. In vivo analysis of the Hsp90 cochaperone Sti1. Mol Cell Biol 1997, 17:318-325.
31. Richter K., Muschler P., Hainzl O., Reinstein J., Buchner J. Sti1 is a non-competitive inhibitor of the Hsp90 ATPase. Binding prevents the N-terminal dimerization reaction during the atpase cycle. J Biol Chem 2003, 278:10328-10333.
32. Song Y., Masison D.C. Independent regulation of Hsp70 and Hsp90 chaperones by Hsp70/Hsp90-organizing protein Sti1. J Biol Chem 2005, 280:34178-34185.
33. Lee P., Shabbir A., Cardozo C., Caplan A.J. Sti1 and Cdc37 can stabilize Hsp90 in chaperone complexes with a protein kinase. Mol Biol Cell 2004, 15:1785-1792.
34. MacLean M., Picard D. Cdc37 goes beyond Hsp90 and kinases. Cell Stress Chaperones 2003, 8:114-119.
35. Siligardi G., Panaretou B., Meyer P., Singh S., Woolfson D.N., Piper P.W., Pearl L.H., Prodromou C. Regulation of Hsp90 ATPase activity by the co-chaperone Cdc37p/p50cdc37. J Biol Chem 2002, 277:20151-20159.
36. Vaughan C.K., Mollapour M., Smith J.R., Truman A., Hu B., Good V.M., Panaretou B., Neckers L., Clarke P.A., Workman P., Piper P.W., Prodromou C., Pearl L.H. Hsp90-dependent activation of protein kinases is regulated by chaperone-targeted dephosphorylation of Cdc37. Mol Cell 2008, 31:886-895.
37. McLaughlin S.H., Sobott F., Yao Z.P., Zhang W., Nielsen P.R., Grossmann J.G., Laue E.D., Robinson C.V., Jackson S.E. The co-chaperone p23 arrests the Hsp90 ATPase cycle to trap client proteins. J Mol Biol 2006, 356:746-758.
38. Picard D. Intracellular dynamics of the Hsp90 co-chaperone p23 is dictated by Hsp90. Exp Cell Res 2006, 312:198-204.
39. Sullivan W.P., Owen B.A., Toft D.O. The influence of ATP and p23 on the conformation of hsp90. J Biol Chem 2002, 277:45942-45948.
40. Lotz G.P., Lin H., Harst A., Obermann W.M. Aha1 binds to the middle domain of Hsp90, contributes to client protein activation, and stimulates the ATPase activity of the molecular chaperone. J Biol Chem 2003, 278:17228-17235.
41. Meyer P., Prodromou C., Liao C., Hu B., Mark Roe S., Vaughan C.K., Vlasic I., Panaretou B., Piper P.W., Pearl L.H. Structural basis for recruitment of the ATPase activator Aha1 to the Hsp90 chaperone machinery. EMBO J 2004, 23:511-519.
42. Panaretou B., Siligardi G., Meyer P., Maloney A., Sullivan J.K., Singh S., Millson S.H., Clarke P.A., Naaby-Hansen S., Stein R., Cramer R., Mollapour M., Workman P., Piper P.W., Pearl L.H., Prodromou C. Activation of the ATPase activity of hsp90 by the stress-regulated cochaperone aha1. Mol Cell 2002, 10:1307-1318.
43. Johnson J.L., Halas A., Flom G. Nucleotide-dependent interaction of Saccharomyces cerevisiae Hsp90 with the cochaperone proteins Sti1, Cpr6, and Sba1. Mol Cell Biol 2007, 27:768-776.
44. Mayr C., Richter K., Lilie H., Buchner J. Cpr6 and Cpr7, two closely related Hsp90-associated immunophilins from Saccharomyces cerevisiae, differ in their functional properties. J Biol Chem 2000, 275:34140-34146.
45. Catlett M.G., Kaplan K.B. Sgt1p is a unique co-chaperone that acts as a client adaptor to link Hsp90 to Skp1p. J Biol Chem 2006, 281:33739-33748.
46. Caplan A.J., Mandal A.K., Theodoraki M.A. Molecular chaperones and protein kinase quality control. Trends Cell Biol 2007, 17:87-92.
47. Zhang M., Boter M., Li K., Kadota Y., Panaretou B., Prodromou C., Shirasu K., Pearl L.H. Structural and functional coupling of Hsp90- and Sgt1-centred multi-protein complexes. EMBO J 2008, 27:2789-2798.
48. Millson S.H., Nuttall J.M., Mollapour M., Piper P.W. The Hsp90/Cdc37p chaperone system is a determinant of molybdate resistance in Saccharomyces cerevisiae. Yeast 2009, 26:339-347.
49. Vaughan C.K., Piper P.W., Pearl L.H., Prodromou C. A common conformationally coupled ATPase mechanism for yeast and human cytoplasmic HSP90s. FEBS J 2009, 276:199-209.
50. Forafonov F., Toogun O.A., Grad I., Suslova E., Freeman B.C., Picard D. p23/Sba1p protects against Hsp90 inhibitors independently of its intrinsic chaperone activity. Mol Cell Biol 2008, 28:3446-3456.
51. Johnson J.L., Brown C. Plasticity of the Hsp90 chaperone machine in divergent eukaryotic organisms. Cell Stress Chaperones 2009, 14:83-94.
52. Miyata Y. Protein kinase CK2 in health and disease: CK2: the kinase controlling the Hsp90 chaperone machinery. Cell Mol Life Sci 2009, 66:1840-1849.
53. Shao J., Prince T., Hartson S.D., Matts R.L. Phosphorylation of serine 13 is required for the proper function of the Hsp90 co-chaperone, Cdc37. J Biol Chem 2003, 278:38117-38120.
54. Bandhakavi S., McCann R.O., Hanna D.E., Glover C.V. A positive feedback loop between protein kinase CKII and Cdc37 promotes the activity of multiple protein kinases. J Biol Chem 2003, 278:2829-2836.
55. Bansal P.K., Mishra A., High A.A., Abdulle R., Kitagawa K. Sgt1 dimerization is negatively regulated by protein kinase CK2-mediated phosphorylation at Ser361. J Biol Chem 2009, 284:18692-18698.
56. Kobayashi T., Nakatani Y., Tanioka T., Tsujimoto M., Nakajo S., Nakaya K., Murakami M., Kudo I. Regulation of cytosolic prostaglandin E synthase by phosphorylation. Biochem J 2004, 381:59-69.
57. Lassle M., Blatch G.L., Kundra V., Takatori T., Zetter B.R. Stress-inducible, murine protein mSTI1. Characterization of binding domains for heat shock proteins and in vitro phosphorylation by different kinases. J Biol Chem 1997, 272:1876-1884.
58. Longshaw V.M., Dirr H.W., Blatch G.L., Lassle M. The in vitro phosphorylation of the co-chaperone mSTI1 by cell cycle kinases substantiates a predicted casein kinase II-p34cdc2-NLS (CcN) motif. Biol Chem 2000, 381:1133-1138.
59. Miyata Y., Chambraud B., Radanyi C., Leclerc J., Lebeau M.C., Renoir J.M., Shirai R., Catelli M.G., Yahara I., Baulieu E.E. Phosphorylation of the immunosuppressant FK506-binding protein FKBP52 by casein kinase II: regulation of HSP90-binding activity of FKBP52. Proc Natl Acad Sci U S A 1997, 94:14500-14505.
60. Zhong L., Qing K., Si Y., Chen L., Tan M., Srivastava A. Heat-shock treatment-mediated increase in transduction by recombinant adeno-associated virus 2 vectors is independent of the cellular heat-shock protein 90. J Biol Chem 2004, 279:12714-12723.
61. Zhao W., Zhong L., Wu J., Chen L., Qing K., Weigel-Kelley K.A., Larsen S.H., Shou W., Warrington K.H., Srivastava A. Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors. Virology 2006, 353:283-293.
62. Qing K., Hansen J., Weigel-Kelley K.A., Tan M., Zhou S., Srivastava A. Adeno-associated virus type 2-mediated gene transfer: role of cellular FKBP52 protein in transgene expression. J Virol 2001, 75:8968-8976.
63. Scroggins B.T., Neckers L. Post-translational modification of heat shock protein 90: impact on chaperone function. Expert Opin Drug Discov 2007, 2:1403-1414.
64. Mollapour M., Tsutsumi S., Neckers L. Hsp90 phosphorylation, Wee1 and the cell cycle. Cell Cycle 2010, 9:2310-2316.
65. Legagneux V., Morange M., Bensaude O. Heat shock increases turnover of 90kDa heat shock protein phosphate groups in HeLa cells. FEBS Lett 1991, 291:359-362.
66. Mimnaugh E.G., Worland P.J., Whitesell L., Neckers L.M. Possible role for serine/threonine phosphorylation in the regulation of the heteroprotein complex between the hsp90 stress protein and the pp 60v-src tyrosine kinase. J Biol Chem 1995, 270:28654-28659.
67. Garnier C., Lafitte D., Jorgensen T.J., Jensen O.N., Briand C., Peyrot V. Phosphorylation and oligomerization states of native pig brain HSP90 studied by mass spectrometry. Eur J Biochem 2001, 268:2402-2407.
68. Zhao Y.G., Gilmore R., Leone G., Coffey M.C., Weber B., Lee P.W. Hsp90 phosphorylation is linked to its chaperoning function. Assembly of the reovirus cell attachment protein. J Biol Chem 2001, 276:32822-32827.
69. Adinolfi E., Kim M., Young M.T., Di Virgilio F., Surprenant A. Tyrosine phosphorylation of HSP90 within the P2X7 receptor complex negatively regulates P2X7 receptors. J Biol Chem 2003, 278:37344-37351.
70. Duval M., Le Boeuf F., Huot J., Gratton J.P. Src-mediated phosphorylation of Hsp90 in response to vascular endothelial growth factor (VEGF) is required for VEGF receptor-2 signaling to endothelial NO synthase. Mol Biol Cell 2007, 18:4659-4668.
71. Miyata Y., Yahara I. The 90-kDa heat shock protein, HSP90, binds and protects casein kinase II from self-aggregation and enhances its kinase activity. J Biol Chem 1992, 267:7042-7047.
72. Old W.M., Shabb J.B., Houel S., Wang H., Couts K.L., Yen C.Y., Litman E.S., Croy C.H., Meyer-Arendt K., Miranda J.G., Brown R.A., Witze E.S., Schweppe R.E., Resing K.A., Ahn N.G. Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanoma. Mol Cell 2009, 34:115-131.
73. Rose D.W., Wettenhall R.E., Kudlicki W., Kramer G., Hardesty B. The 90-kilodalton peptide of the heme-regulated eIF-2 alpha kinase has sequence similarity with the 90-kilodalton heat shock protein. Biochemistry 1987, 26:6583-6587.
74. Wang X., Song X., Zhuo W., Fu Y., Shi H., Liang Y., Tong M., Chang G., Luo Y. The regulatory mechanism of Hsp90{alpha} secretion and its function in tumor malignancy. Proc Natl Acad Sci U S A 2009, 106:21288-21293.
75. Mollapour M., Tsutsumi S., Truman A.W., Xu W., Vaughan C.K., Beebe K., Konstantinova A., Vourganti S., Panaretou B., Piper P.W., Trepel J.B., Prodromou C., Pearl L.H., Neckers L. Threonine 22 phosphorylation attenuates hsp90 interaction with cochaperones and affects its chaperone activity. Mol Cell 2011, 41:672-681.
76. Mollapour M., Tsutsumi S., Kim Y.S., Trepel J., Neckers L. Casein kinase 2 phosphorylation of Hsp90 threonine 22 modulates chaperone function and drug sensitivity. Oncotarget 2011, 2:407-417.
77. Mollapour M., Tsutsumi S., Donnelly A.C., Beebe K., Tokita M.J., Lee M.J., Lee S., Morra G., Bourboulia D., Scroggins B.T., Colombo G., Blagg B.S., Panaretou B., Stetler-Stevenson W.G., Trepel J.B., Piper P.W., Prodromou C., Pearl L.H., Neckers L. Swe1Wee1-dependent tyrosine phosphorylation of Hsp90 regulates distinct facets of chaperone function. Mol Cell 2010, 37:333-343.
78. Ogiso H., Kagi N., Matsumoto E., Nishimoto M., Arai R., Shirouzu M., Mimura J., Fujii-Kuriyama Y., Yokoyama S. Phosphorylation analysis of 90kDa heat shock protein within the cytosolic arylhydrocarbon receptor complex. Biochemistry 2004, 43:15510-15519.
79. Wandinger S.K., Suhre M.H., Wegele H., Buchner J. The phosphatase Ppt1 is a dedicated regulator of the molecular chaperone Hsp90. EMBO J 2006, 25:367-376.
80. Brouet A., Sonveaux P., Dessy C., Moniotte S., Balligand J.L., Feron O. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins. Circ Res 2001, 89:866-873.
81. Bennetzen M.V., Larsen D.H., Bunkenborg J., Bartek J., Lukas J., Andersen J.S. Site-specific phosphorylation dynamics of the nuclear proteome during the DNA damage response. Mol Cell Proteomics 2010, 9:1314-1323.
82. Wang Z., Gucek M., Hart G.W. Cross-talk between GlcNAcylation and phosphorylation: site-specific phosphorylation dynamics in response to globally elevated O-GlcNAc. Proc Natl Acad Sci U S A 2008, 105:13793-13798.
83. Choudhary C., Olsen J.V., Brandts C., Cox J., Reddy P.N., Bohmer F.D., Gerke V., Schmidt-Arras D.E., Berdel W.E., Muller-Tidow C., Mann M., Serve H. Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes. Mol Cell 2009, 36:326-339.
84. Guo A., Villen J., Kornhauser J., Lee K.A., Stokes M.P., Rikova K., Possemato A., Nardone J., Innocenti G., Wetzel R., Wang Y., MacNeill J., Mitchell J., Gygi S.P., Rush J., Polakiewicz R.D., Comb M.J. Signaling networks assembled by oncogenic EGFR and c-Met. Proc Natl Acad Sci U S A 2008, 105:692-697.
85. Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J., Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X., Gygi S.P., Gu T.L., Polakiewicz R.D., Rush J., Comb M.J. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007, 131:1190-1203.
86. Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P. A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 2010, 143:1174-1189.
87. Moritz A., Li Y., Guo A., Villen J., Wang Y., MacNeill J., Kornhauser J., Sprott K., Zhou J., Possemato A., Ren J.M., Hornbeck P., Cantley L.C., Gygi S.P., Rush J., Comb M.J. Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases. Sci Signal 2010, 3:ra64.
88. Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127:635-648.
89. Wisniewski J.R., Nagaraj N., Zougman A., Gnad F., Mann M. Brain phosphoproteome obtained by a FASP-based method reveals plasma membrane protein topology. J Proteome Res 2010, 9:3280-3289.
90. Han G., Ye M., Liu H., Song C., Sun D., Wu Y., Jiang X., Chen R., Wang C., Wang L., Zou H. Phosphoproteome analysis of human liver tissue by long-gradient nanoflow LC coupled with multiple stage MS analysis. Electrophoresis 2010, 31:1080-1089.
91. Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P. Large-scale phosphorylation analysis of mouse liver. Proc Natl Acad Sci U S A 2007, 104:1488-1493.
92. Hoffert J.D., Wang G., Pisitkun T., Shen R.F., Knepper M.A. An automated platform for analysis of phosphoproteomic datasets: application to kidney collecting duct phosphoproteins. J Proteome Res 2007, 6:3501-3508.
93. Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A 2008, 105:10762-10767.
94. Xia Q., Cheng D., Duong D.M., Gearing M., Lah J.J., Levey A.I., Peng J. Phosphoproteomic analysis of human brain by calcium phosphate precipitation and mass spectrometry. J Proteome Res 2008, 7:2845-2851.
95. Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal 2009, 2:ra46.
96. Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316:1160-1166.
97. Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P. Large-scale identification and evolution indexing of tyrosine phosphorylation sites from murine brain. J Proteome Res 2008, 7:311-318.
98. Jorgensen C., Sherman A., Chen G.I., Pasculescu A., Poliakov A., Hsiung M., Larsen B., Wilkinson D.G., Linding R., Pawson T. Cell-specific information processing in segregating populations of Eph receptor ephrin-expressing cells. Science 2009, 326:1502-1509.
99. Bonnette P.C., Robinson B.S., Silva J.C., Stokes M.P., Brosius A.D., Baumann A., Buckbinder L. Phosphoproteomic characterization of PYK2 signaling pathways involved in osteogenesis. J Proteomics 2010, 73:1306-1320.
100. Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H. A multidimensional chromatography technology for in-depth phosphoproteome analysis. Mol Cell Proteomics 2008, 7:1389-1396.
101. Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A. Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry. Proc Natl Acad Sci U S A 2007, 104:2199-2204.
102. Lees-Miller S.P., Anderson C.W. The human double-stranded DNA-activated protein kinase phosphorylates the 90-kDa heat-shock protein, hsp90 alpha at two NH2-terminal threonine residues. J Biol Chem 1989, 264:17275-17280.
103. Barati M.T., Rane M.J., Klein J.B., McLeish K.R. A proteomic screen identified stress-induced chaperone proteins as targets of Akt phosphorylation in mesangial cells. J Proteome Res 2006, 5:1636-1646.
104. Huang S.Y., Tsai M.L., Chen G.Y., Wu C.J., Chen S.H. A systematic MS-based approach for identifying in vitro substrates of PKA and PKG in rat uteri. J Proteome Res 2007, 6:2674-2684.
105. Lei H., Venkatakrishnan A., Yu S., Kazlauskas A. Protein kinase A-dependent translocation of Hsp90 alpha impairs endothelial nitric-oxide synthase activity in high glucose and diabetes. J Biol Chem 2007, 282:9364-9371.
106. Cheng C.F., Fan J., Fedesco M., Guan S., Li Y., Bandyopadhyay B., Bright A.M., Yerushalmi D., Liang M., Chen M., Han Y.P., Woodley D.T., Li W. Transforming growth factor alpha (TGFalpha)-stimulated secretion of HSP90alpha: using the receptor LRP-1/CD91 to promote human skin cell migration against a TGFbeta-rich environment during wound healing. Mol Cell Biol 2008, 28:3344-3358.
107. Tsutsumi S., Scroggins B., Koga F., Lee M.J., Trepel J., Felts S., Carreras C., Neckers L. A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion. Oncogene 2008, 27:2478-2487.
108. Ruzzene M., Pinna L.A. Addiction to protein kinase CK2: a common denominator of diverse cancer cells?. Biochim Biophys Acta 2010, 1804:499-504.
109. Dougherty J.J., Rabideau D.A., Iannotti A.M., Sullivan W.P., Toft D.O. Identification of the 90kDa substrate of rat liver type II casein kinase with the heat shock protein which binds steroid receptors. Biochim Biophys Acta 1987, 927:74-80.
110. Lees-Miller S.P., Anderson C.W. Two human 90-kDa heat shock proteins are phosphorylated in vivo at conserved serines that are phosphorylated in vitro by casein kinase II. J Biol Chem 1989, 264:2431-2437.
111. Kurokawa M., Zhao C., Reya T., Kornbluth S. Inhibition of apoptosome formation by suppression of Hsp90beta phosphorylation in tyrosine kinase-induced leukemias. Mol Cell Biol 2008, 28:5494-5506.
112. Harvey S.L., Kellogg D.R. Conservation of mechanisms controlling entry into mitosis: budding yeast wee1 delays entry into mitosis and is required for cell size control. Curr Biol 2003, 13:264-275.
113. Lew D.J. The morphogenesis checkpoint: how yeast cells watch their figures. Curr Opin Cell Biol 2003, 15:648-653.
114. Booher R.N., Deshaies R.J., Kirschner M.W. Properties of Saccharomyces cerevisiae wee1 and its differential regulation of p34CDC28 in response to G1 and G2 cyclins. EMBO J 1993, 12:3417-3426.
115. Cunningham C.N., Krukenberg K.A., Agard D.A. Intra- and intermonomer interactions are required to synergistically facilitate ATP hydrolysis in Hsp90. J Biol Chem 2008, 283:21170-21178.
116. Morra G., Verkhivker G., Colombo G. Modeling signal propagation mechanisms and ligand-based conformational dynamics of the Hsp90 molecular chaperone full-length dimer. PLoS Comput Biol 2009, 5:e1000323.
117. Yu X., Guo Z.S., Marcu M.G., Neckers L., Nguyen D.M., Chen G.A., Schrump D.S. Modulation of p53, ErbB1, ErbB2, and Raf-1 expression in lung cancer cells by depsipeptide FR901228. J Natl Cancer Inst 2002, 94:504-513.
118. Nimmanapalli R., Fuino L., Bali P., Gasparetto M., Glozak M., Tao J., Moscinski L., Smith C., Wu J., Jove R., Atadja P., Bhalla K. Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells. Cancer Res 2003, 63:5126-5135.
119. Nimmanapalli R., Fuino L., Stobaugh C., Richon V., Bhalla K. Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl-positive human acute leukemia cells. Blood 2003, 101:3236-3239.
120. Bali P., Pranpat M., Bradner J., Balasis M., Fiskus W., Guo F., Rocha K., Kumaraswamy S., Boyapalle S., Atadja P., Seto E., Bhalla K. Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors. J Biol Chem 2005, 280:26729-26734.
121. Kovacs J.J., Murphy P.J., Gaillard S., Zhao X., Wu J.T., Nicchitta C.V., Yoshida M., Toft D.O., Pratt W.B., Yao T.P. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol Cell 2005, 18:601-607.
122. Kekatpure V.D., Dannenberg A.J., Subbaramaiah K. HDAC6 modulates Hsp90 chaperone activity and regulates activation of aryl hydrocarbon receptor signaling. J Biol Chem 2009, 284:7436-7445.
123. Murphy P.J., Morishima Y., Kovacs J.J., Yao T.P., Pratt W.B. Regulation of the dynamics of hsp90 action on the glucocorticoid receptor by acetylation/deacetylation of the chaperone. J Biol Chem 2005, 280:33792-33799.
124. Zhang Y., Kwon S., Yamaguchi T., Cubizolles F., Rousseaux S., Kneissel M., Cao C., Li N., Cheng H.L., Chua K., Lombard D., Mizeracki A., Matthias G., Alt F.W., Khochbin S., Matthias P. Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally. Mol Cell Biol 2008, 28:1688-1701.
125. Ai J., Wang Y., Dar J.A., Liu J., Liu L., Nelson J.B., Wang Z. HDAC6 regulates androgen receptor hypersensitivity and nuclear localization via modulating Hsp90 acetylation in castration-resistant prostate cancer. Mol Endocrinol 2009, 23:1963-1972.
126. Zhang D., Li J., Costa M., Gao J., Huang C. JNK1 mediates degradation HIF-1alpha by a VHL-independent mechanism that involves the chaperones Hsp90/Hsp70. Cancer Res 2010, 70:813-823.
127. Park J.H., Kim S.H., Choi M.C., Lee J., Oh D.Y., Im S.A., Bang Y.J., Kim T.Y. Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors. Biochem Biophys Res Commun 2008, 368:318-322.
128. de Zoeten E.F., Wang L., Butler K., Beier U.H., Akimova T., Sai H., Bradner J.E., Mazitschek R., Kozikowski A.P., Matthias P., Hancock W.W. Histone deacetylase 6 and heat shock protein 90 control the functions of foxp3+ T-regulatory cells. Mol Cell Biol 2011, 31:2066-2078.
129. Zhou Q., Agoston A.T., Atadja P., Nelson W.G., Davidson N.E. Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cells. Mol Cancer Res 2008, 6:873-883.
130. Scroggins B.T., Robzyk K., Wang D., Marcu M.G., Tsutsumi S., Beebe K., Cotter R.J., Felts S., Toft D., Karnitz L., Rosen N., Neckers L. An acetylation site in the middle domain of Hsp90 regulates chaperone function. Mol Cell 2007, 25:151-159.
131. Yang Y., Rao R., Shen J., Tang Y., Fiskus W., Nechtman J., Atadja P., Bhalla K. Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion. Cancer Res 2008, 68:4833-4842.
132. Martinez-Ruiz A., Villanueva L., Gonzalez de Orduna C., Lopez-Ferrer D., Higueras M.A., Tarin C., Rodriguez-Crespo I., Vazquez J., Lamas S. S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities. Proc Natl Acad Sci U S A 2005, 102:8525-8530.
133. Retzlaff M., Stahl M., Eberl H.C., Lagleder S., Beck J., Kessler H., Buchner J. Hsp90 is regulated by a switch point in the C-terminal domain. EMBO Rep 2009, 10:1147-1153.
134. Chen W.Y., Chang F.R., Huang Z.Y., Chen J.H., Wu Y.C., Wu C.C. Tubocapsenolide A, a novel withanolide, inhibits proliferation and induces apoptosis in MDA-MB-231 cells by thiol oxidation of heat shock proteins. J Biol Chem 2008, 283:17184-17193.
135. Carbone D.L., Doorn J.A., Kiebler Z., Ickes B.R., Petersen D.R. Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease. J Pharmacol Exp Ther 2005, 315:8-15.
136. Blank M., Mandel M., Keisari Y., Meruelo D., Lavie G. Enhanced ubiquitinylation of heat shock protein 90 as a potential mechanism for mitotic cell death in cancer cells induced with hypericin. Cancer Res 2003, 63:8241-8247.
137. Murtagh J., Lu H., Schwartz E.L. Taxotere-induced inhibition of human endothelial cell migration is a result of heat shock protein 90 degradation. Cancer Res 2006, 66:8192-8199.
138. Street T.O., Lavery L.A., Agard D.A. Substrate binding drives large-scale conformational changes in the hsp90 molecular chaperone. Mol Cell 2011, 42:96-105.